Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
Vaccine|December 18, 2019
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I studyÉlodie Pastural, Shelly A McNeil, Donna MacKinnon-Cameron, et al.
Clinical and Vaccine Immunology : CVI|July 25, 2014
A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococciAniela Wozniak, Patricia García, Enrique A Geoffroy, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2015
Protective immunogenicity of group A streptococcal M-related proteinsJames B Dale, Shannon E Niedermeyer, Tina Agbaosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing MonitoringEdwin J Asturias, Jean-Louis Excler, James Ackland, et al.
The Pediatric Infectious Disease Journal|October 31, 2014
Streptococcal pharyngitis in schoolchildren in Bamako, MaliMilagritos D Tapia, Samba O Sow, Boubou Tamboura, et al.
Vaccine|April 20, 2013
Group A streptococcal vaccines: paving a path for accelerated developmentJames B Dale, Vincent A Fischetti, Jonathan R Carapetis, et al.
The New England Journal of Medicine|April 14, 2016
Two-Year Costs and Quality in the Comprehensive Primary Care InitiativeStacy B Dale, Arkadipta Ghosh, Deborah N Peikes, et al.
Nature Neuroscience|April 13, 2010
CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signalingAna C Magalhaes, Kevin D Holmes, Lianne B Dale, et al.
Vaccine|August 1, 2014
Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infectionJoshua M Klonoski, Heather R Hurtig, Brian A Juber, et al.
BMJ Global Health|November 1, 2023
Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop reportJoselyn Rwebembera, Jeffrey W Cannon, Amy Sanyahumbi, et al.
Pageof 30